What did TA Associates Management pay for Elos Medtech?

TA Associates Management acquired Elos Medtech for $252.7M in 2021 (13.9x EBITDA), equivalent to 3.00x revenue. Target revenue was approximately $83.9M. Target EBITDA was approximately $18.1M.

What does Elos Medtech do?

Elos Medtech is a medical devices business.

What multiple did TA Associates Management pay for Elos Medtech?

13.9x EBITDA and 3.00x revenue, based on disclosed deal value of $252.7M and disclosed financials.

M&A TRANSACTION · 2021

Elos Medtech acquired by TA Associates Management

$252.7M· 13.9x EBITDA· 3.00x revenue

Target

Elos Medtech

Acquirer

TA Associates Management

Disclosed financials at time of acquisition

Revenue

$83.9M

EBITDA

$18.1M

Deal Value

$252.7M

EV/EBITDA

13.9x

Context

This $252.7M acquisition of Elos Medtech by TA Associates Management sits in the medical devices sub-vertical. The 13.9x EBITDA multiple paid in 2021 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub.

Source

Data sourced from Press releases, financial statements, investment research note. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Elos Medtech acquisition.

Citation: ExitValue.ai. (2021). Elos Medtech acquired by TA Associates Management. https://exitvalue.ai/deals/elos-medtech-acquired-by-ta-associates-management-hc-2021-0092